Health Consequences of the Burden of Atrial Fibrillation
NCT ID: NCT05389228
Last Updated: 2024-03-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
325 participants
OBSERVATIONAL
2018-08-01
2024-01-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Mechanistic Exploratory Study of AF-induced Cardiac Dysfunction and Symptoms
NCT04987723
Swiss Atrial Fibrillation Cohort Study
NCT02105844
Symptom Preoccupation in Atrial Fibrillation (AF) and Its Role in AF-related Disability
NCT04123327
Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
NCT06207383
Progression of Atrial Fibrillation in the Young
NCT05080712
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Paroxysmal or persistent AF
Exclusion Criteria
* Swiss-AF patients not willing or able to undergo 7-day Holter monitoring
* Specifically for cMRI: Pregnant women or women of child-bearing age without a prior negative pregnancy test
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swiss National Science Foundation
OTHER
Clinical Trial Unit, University Hospital Basel, Switzerland
OTHER
Swiss Heart Foundation
OTHER
Insel Gruppe AG, University Hospital Bern
OTHER
University Hospital, Geneva
OTHER
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Kühne
Prof. Dr. med.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Kuehne, MD Prof, exec MBA
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Basel, Switzerland
Laurent Roten, MD Prof
Role: PRINCIPAL_INVESTIGATOR
University Hospital Insel, Bern, Switzerland
Dipen Shah, MD Prof
Role: PRINCIPAL_INVESTIGATOR
Hôpitaux Universitaires de Genève, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Basel
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Swiss-AF-BURDEN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.